Non-diabetic nephropathy in diabetic patients: incidence, HbA1c variability and other predictive factors, and implications
- 25 April 2024
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (9) , 3091-3100
Abstract
Purpose Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD) in the population. In patients with diabetes mellitus, the incidence of non-diabetic nephropathy (NDNP) has been estimated to range from 3% to 69.5%. Personal judgment is frequently employed while deciding whether or not to do a kidney biopsy (KB) on diabetic patients. NDNP alters the prognosis and course of treatment for people with DM. In our study, we examined the incidence of NDNP concurrent with the progression of diabetes mellitus, as well as the laboratory and clinical indicators that could be utilized to forecast it. Methods A retrospective analysis of 76 diabetic patients who underwent KB was conducted. Based on the pathological diagnoses of these patients, they were categorized as DNP (diabetic nephropathy) or NDNP. The definition of HbA1c variability was determined by calculating the mean HbA1c and the average value of the HbA1c measurements, as well as the standard deviation (SD) for each participant. Results NDNP was detected in 50% of 76 patients. Among patients with NDNP, 36.8% had focal segmental glomerulosclerosis (FSGS), 23.6% had membranous glomerulonephritis, and 7.8% had IgA nephritis. The NDNP group exhibited significantly higher rates of female gender, absence of diabetic retinopathy, shorter time to diagnosis of diabetes mellitus, chronic kidney disease, and proteinuria, less intensive medication for diabetes mellitus, presence of hematuria and leukociduria, immunological serological marker positivity, and non-HbA1C variability. Risk factors for predicting non-diabetic nephropathy, as determined by multivariate analysis, included female gender, the absence of diabetic retinopathy, non-HbA1c variability and a positive immunological serological test. Conclusion In this study, a significant number of diabetic patients with chronic kidney disease were diagnosed with NDNP. Identifying these patients allows for treatment of the specific underlying disease. Factors such as the absence of DR, non-HbA1c variability, female gender, and immunological serological test positivity can predict NDNP and guide the clinician’s decision on kidney biopsy. Further prospective studies are warranted to validate the efficacy of potential predictive factors like HbA1c variability.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis updateActa Diabetologica, 2023
- Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitusDiabetes Research and Clinical Practice, 2022
- Characterizing predictors of non-diabetic kidney disease (NDKD) in diabetic patientsInternational Urology and Nephrology, 2021
- Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patientsDiabetes Research and Clinical Practice, 2016
- Predicting non-diabetic renal disease in type 2 diabetic adults: The value of glycated hemoglobinJournal of Diabetes and its Complications, 2015
- Diabetes: a 21st century challengeThe Lancet Diabetes & Endocrinology, 2014
- Risks of Diabetic Nephropathy with Variation in Hemoglobin A1c and Fasting Plasma GlucoseThe American Journal of Medicine, 2013
- Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 casesInternational Urology and Nephrology, 2012
- Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathyKidney International, 2000
- Nondiabetic renal disease complicating diabetic nephropathyJournal of Diabetic Complications, 1991